{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:45Z","timestamp":1791918945312,"version":"4.3.4"},"publisher-location":"Cham","reference-count":75,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030357269","type":"print"},{"value":"9783030357276","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-35727-6_10","type":"book-chapter","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T16:07:08Z","timestamp":1581005228000},"page":"137-153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["The Microbiome as a Component of the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"T\u00fcnde","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Mik\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"Ujlaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsanett","family":"S\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"issue":"9","key":"10_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006480","volume":"13","author":"LE Fulbright","year":"2017","unstructured":"Fulbright LE, Ellermann M, Arthur JC (2017) The microbiome and the hallmarks of cancer. PLoS Pathog 13(9):e1006480","journal-title":"PLoS Pathog"},{"issue":"5","key":"10_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.chom.2017.10.005","volume":"22","author":"P Maruvada","year":"2017","unstructured":"Maruvada P et al (2017) The human microbiome and obesity: moving beyond associations. Cell Host Microbe 22(5):589\u2013599","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.7453\/gahmj.2013.089","volume":"2","author":"D Macfabe","year":"2013","unstructured":"Macfabe D (2013) Autism: metabolism, mitochondria, and the microbiome. Glob Adv Health Med 2(6):52\u201366","journal-title":"Glob Adv Health Med"},{"issue":"7","key":"10_CR4","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2017.11.024","volume":"171","author":"P Kundu","year":"2017","unstructured":"Kundu P et al (2017) Our gut microbiome: the evolving inner self. Cell 171(7):1481\u20131493","journal-title":"Cell"},{"issue":"4","key":"10_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","volume":"10","author":"CS Plottel","year":"2011","unstructured":"Plottel CS, Blaser MJ (2011) Microbiome and malignancy. Cell Host Microbe 10(4):324\u2013335","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe RF, Jobin C (2013) The microbiome and cancer. Nat Rev Cancer 13(11):800\u2013812","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cell.2016.03.001","volume":"165","author":"L Zitvogel","year":"2016","unstructured":"Zitvogel L et al (2016) Microbiome and anticancer immunosurveillance. Cell 165(2):276\u2013287","journal-title":"Cell"},{"issue":"2","key":"10_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5114\/aoms.2015.50970","volume":"11","author":"H Yu","year":"2015","unstructured":"Yu H et al (2015) Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia. Arch Med Sci 11(2):385\u2013394","journal-title":"Arch Med Sci"},{"issue":"1","key":"10_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2015.04.036","volume":"138","author":"D Chase","year":"2015","unstructured":"Chase D et al (2015) The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Gynecol Oncol 138(1):190\u2013200","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10_CR10","first-page":"461","volume":"14","author":"Y Yu","year":"2015","unstructured":"Yu Y et al (2015) The role of the cutaneous microbiome in skin cancer: lessons learned from the gut. J Drugs Dermatol 14(5):461\u2013465","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10_CR11","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.4238\/2015.May.25.16","volume":"14","author":"QF Gui","year":"2015","unstructured":"Gui QF et al (2015) Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model. Genet Mol Res 14(2):5642\u20135651","journal-title":"Genet Mol Res"},{"issue":"6230","key":"10_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"Garrett WS (2015) Cancer and the microbiota. Science 348(6230):80\u201386","journal-title":"Science"},{"issue":"9","key":"10_CR13","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.3390\/ijerph110909038","volume":"11","author":"ML Yamamoto","year":"2014","unstructured":"Yamamoto ML, Schiestl RH (2014) Lymphoma caused by intestinal microbiota. Int J Environ Res Public Health 11(9):9038\u20139049","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/PPO.0000000000000047","volume":"20","author":"ML Yamamoto","year":"2014","unstructured":"Yamamoto ML, Schiestl RH (2014) Intestinal microbiome and lymphoma development. Cancer J 20(3):190\u2013194","journal-title":"Cancer J"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1479-5876-10-253","volume":"10","author":"R Flores","year":"2012","unstructured":"Flores R et al (2012) Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med 10:253","journal-title":"J Transl Med"},{"issue":"12","key":"10_CR16","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1210\/jc.2014-2222","volume":"99","author":"BJ Fuhrman","year":"2014","unstructured":"Fuhrman BJ et al (2014) Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab 99(12):4632\u20134640","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083744","volume":"9","author":"C Xuan","year":"2014","unstructured":"Xuan C et al (2014) Microbial dysbiosis is associated with human breast cancer. PLoS One 9(1):e83744","journal-title":"PLoS One"},{"issue":"8","key":"10_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv147","volume":"107","author":"JJ Goedert","year":"2015","unstructured":"Goedert JJ et al (2015) Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst 107(8):djv147","journal-title":"J Natl Cancer Inst"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"28061","DOI":"10.1038\/srep28061","volume":"6","author":"AA Chan","year":"2016","unstructured":"Chan AA et al (2016) Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors. Sci Rep 6:28061","journal-title":"Sci Rep"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"30751","DOI":"10.1038\/srep30751","volume":"6","author":"TJ Hieken","year":"2016","unstructured":"Hieken TJ et al (2016) The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep 6:30751","journal-title":"Sci Rep"},{"issue":"16","key":"10_CR21","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1128\/AEM.01235-16","volume":"82","author":"C Urbaniak","year":"2016","unstructured":"Urbaniak C et al (2016) The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol 82(16):5039\u20135048","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"10_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/bjc.2017.435","volume":"118","author":"JJ Goedert","year":"2018","unstructured":"Goedert JJ et al (2018) Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota. Br J Cancer 118(4):471\u2013479","journal-title":"Br J Cancer"},{"issue":"4","key":"10_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/intimm\/dxp017","volume":"21","author":"T Kawai","year":"2009","unstructured":"Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21(4):317\u2013337","journal-title":"Int Immunol"},{"issue":"4","key":"10_CR24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito DH et al (2012) Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21(4):504\u2013516","journal-title":"Cancer Cell"},{"key":"10_CR25","first-page":"x","volume-title":"Role of the gut flora in toxicity and cancer","author":"IR Rowland","year":"1988","unstructured":"Rowland IR (1988) Role of the gut flora in toxicity and cancer. Academic Press, London, p x, 517 p"},{"issue":"7456","key":"10_CR26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature12347","volume":"499","author":"S Yoshimoto","year":"2013","unstructured":"Yoshimoto S et al (2013) Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499(7456):97\u2013101","journal-title":"Nature"},{"issue":"8","key":"10_CR27","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/ijc.30219","volume":"139","author":"G Xie","year":"2016","unstructured":"Xie G et al (2016) Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis. Int J Cancer 139(8):1764\u20131775","journal-title":"Int J Cancer"},{"issue":"5","key":"10_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/coa.12822","volume":"42","author":"Z Shellman","year":"2017","unstructured":"Shellman Z et al (2017) Bile acids: a potential role in the pathogenesis of pharyngeal malignancy. Clin Otolaryngol 42(5):969\u2013973","journal-title":"Clin Otolaryngol"},{"issue":"1","key":"10_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s13402-017-0353-5","volume":"41","author":"TH Luu","year":"2018","unstructured":"Luu TH et al (2018) Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells. Cell Oncol (Dordr) 41(1):13\u201324","journal-title":"Cell Oncol (Dordr)"},{"issue":"9","key":"10_CR30","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbabio.2018.04.002","volume":"1859","author":"E Miko","year":"2018","unstructured":"Miko E et al (2018) Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness. Biochim Biophys Acta Bioenerg 1859(9):958\u2013974","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"8","key":"10_CR31","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/bjc.2012.409","volume":"107","author":"LB Bindels","year":"2012","unstructured":"Bindels LB et al (2012) Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br J Cancer 107(8):1337\u20131344","journal-title":"Br J Cancer"},{"issue":"1","key":"10_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/09674845.2012.11669916","volume":"69","author":"AJ McCarron","year":"2012","unstructured":"McCarron AJ et al (2012) Antibacterial effects on acinetobacter species of commonly employed antineoplastic agents used in the treatment of haematological malignancies: an in vitro laboratory evaluation. Br J Biomed Sci 69(1):14\u201317","journal-title":"Br J Biomed Sci"},{"issue":"6161","key":"10_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud S et al (2013) The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342(6161):971\u2013976","journal-title":"Science"},{"issue":"5","key":"10_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","volume":"42","author":"E Montassier","year":"2015","unstructured":"Montassier E et al (2015) Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther 42(5):515\u2013528","journal-title":"Aliment Pharmacol Ther"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/bs.acr.2019.03.005","volume":"143","author":"C Buchta Rosean","year":"2019","unstructured":"Buchta Rosean C et al (2019) Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res 143:255\u2013294","journal-title":"Adv Cancer Res"},{"issue":"12","key":"10_CR36","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1099\/jmm.0.000371","volume":"65","author":"V Garcia-Castillo","year":"2016","unstructured":"Garcia-Castillo V et al (2016) Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle. J Med Microbiol 65(12):1347\u20131362","journal-title":"J Med Microbiol"},{"issue":"44","key":"10_CR37","doi-asserted-by":"publisher","first-page":"16452","DOI":"10.3748\/wjg.v20.i44.16452","volume":"20","author":"N Arslan","year":"2014","unstructured":"Arslan N (2014) Obesity, fatty liver disease and intestinal microbiota. World J Gastroenterol 20(44):16452\u201316463","journal-title":"World J Gastroenterol"},{"issue":"24","key":"10_CR38","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","volume":"375","author":"SV Lynch","year":"2016","unstructured":"Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375(24):2369\u20132379","journal-title":"N Engl J Med"},{"issue":"2","key":"10_CR39","first-page":"331","volume":"1826","author":"AA Khan","year":"2012","unstructured":"Khan AA, Shrivastava A, Khurshid M (2012) Normal to cancer microbiome transformation and its implication in cancer diagnosis. Biochim Biophys Acta 1826(2):331\u2013337","journal-title":"Biochim Biophys Acta"},{"issue":"22","key":"10_CR40","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1016\/j.febslet.2014.03.035","volume":"588","author":"CJ Walsh","year":"2014","unstructured":"Walsh CJ et al (2014) Beneficial modulation of the gut microbiota. FEBS Lett 588(22):4120\u20134130","journal-title":"FEBS Lett"},{"issue":"7","key":"10_CR41","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/cmi.12308","volume":"16","author":"C Petersen","year":"2014","unstructured":"Petersen C, Round JL (2014) Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol 16(7):1024\u20131033","journal-title":"Cell Microbiol"},{"issue":"1","key":"10_CR42","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41598-018-37664-7","volume":"9","author":"T Kovacs","year":"2019","unstructured":"Kovacs T et al (2019) Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors. Sci Rep 9(1):1300","journal-title":"Sci Rep"},{"issue":"5","key":"10_CR43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"23","key":"10_CR44","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1242\/jcs.116392","volume":"125","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125(23):5591\u20135596","journal-title":"J Cell Sci"},{"issue":"8","key":"10_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15081747","volume":"15","author":"MF Fernandez","year":"2018","unstructured":"Fernandez MF et al (2018) Breast cancer and its relationship with the microbiota. Int J Environ Res Public Health 15(8):E1747","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1053\/j.sempedsurg.2013.01.003","volume":"22","author":"DJ Hackam","year":"2013","unstructured":"Hackam DJ, Good M, Sodhi CP (2013) Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: toll-like receptors throw the switch. Semin Pediatr Surg 22(2):76\u201382","journal-title":"Semin Pediatr Surg"},{"issue":"26","key":"10_CR47","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR et al (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366(26):2455\u20132465","journal-title":"N Engl J Med"},{"issue":"8","key":"10_CR48","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/CJI.0b013e318156e47e","volume":"30","author":"JC Yang","year":"2007","unstructured":"Yang JC et al (2007) Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother 30(8):825\u2013830","journal-title":"J Immunother"},{"issue":"26","key":"10_CR49","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366(26):2443\u20132454","journal-title":"N Engl J Med"},{"issue":"6264","key":"10_CR50","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M Vetizou","year":"2015","unstructured":"Vetizou M et al (2015) Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350(6264):1079\u20131084","journal-title":"Science"},{"issue":"6264","key":"10_CR51","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan A et al (2015) Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350(6264):1084\u20131089","journal-title":"Science"},{"issue":"6371","key":"10_CR52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97\u2013103","journal-title":"Science"},{"issue":"6371","key":"10_CR53","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V et al (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359(6371):104\u2013108","journal-title":"Science"},{"issue":"6371","key":"10_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B et al (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359(6371):91\u201397","journal-title":"Science"},{"issue":"2","key":"10_CR55","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"JM Ridlon","year":"2006","unstructured":"Ridlon JM, Kang DJ, Hylemon PB (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47(2):241\u2013259","journal-title":"J Lipid Res"},{"issue":"10","key":"10_CR56","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro3344","volume":"12","author":"P Louis","year":"2014","unstructured":"Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12(10):661\u2013672","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040293","volume":"8","author":"E Miko","year":"2019","unstructured":"Miko E et al (2019) Microbiome-microbial metabolome-cancer cell interactions in breast cancer-familiar, but unexplored. Cell 8(4):E293","journal-title":"Cell"},{"issue":"2","key":"10_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020089","volume":"8","author":"N Gandhi","year":"2019","unstructured":"Gandhi N, Das GM (2019) Metabolic reprogramming in breast cancer and its therapeutic implications. Cell 8(2):E89","journal-title":"Cell"},{"issue":"43","key":"10_CR59","doi-asserted-by":"publisher","first-page":"E9066","DOI":"10.1073\/pnas.1704862114","volume":"114","author":"P Sansone","year":"2017","unstructured":"Sansone P et al (2017) Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proc Natl Acad Sci U S A 114(43):E9066\u2013E9075","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"10_CR60","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1089\/scd.2017.0035","volume":"26","author":"J Ivan","year":"2017","unstructured":"Ivan J et al (2017) The short-chain fatty acid propionate inhibits adipogenic differentiation of human chorion-derived mesenchymal stem cells through the free fatty acid receptor 2. Stem Cells Dev 26(23):1724\u20131733","journal-title":"Stem Cells Dev"},{"key":"10_CR61","doi-asserted-by":"publisher","unstructured":"Fruge AD et al (2018) Fecal Akkermansia muciniphila is associated with body composition and microbiota diversity in overweight and obese women with breast Cancer participating in a presurgical weight loss trial. J Acad Nutr Diet. https:\/\/doi.org\/10.1016\/j.jand.2018.08.164","DOI":"10.1016\/j.jand.2018.08.164"},{"issue":"20","key":"10_CR62","doi-asserted-by":"publisher","first-page":"10120","DOI":"10.1158\/0008-5472.CAN-06-2399","volume":"66","author":"KE Swales","year":"2006","unstructured":"Swales KE et al (2006) The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression. Cancer Res 66(20):10120\u201310126","journal-title":"Cancer Res"},{"issue":"1","key":"10_CR63","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/13556219772840","volume":"2","author":"M Salaspuro","year":"1997","unstructured":"Salaspuro M (1997) Microbial metabolism of ethanol and acetaldehyde and clinical consequences. Addict Biol 2(1):35\u201346","journal-title":"Addict Biol"},{"issue":"5","key":"10_CR64","first-page":"4335","volume":"18","author":"A Vida","year":"2018","unstructured":"Vida A et al (2018) Deletion of poly(ADPribose) polymerase-1 changes the composition of the microbiome in the gut. Mol Med Rep 18(5):4335\u20134341","journal-title":"Mol Med Rep"},{"issue":"9","key":"10_CR65","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan XC et al (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13(9):R79","journal-title":"Genome Biol"},{"issue":"3\u20134","key":"10_CR66","first-page":"375","volume":"383","author":"GI Giles","year":"2002","unstructured":"Giles GI, Jacob C (2002) Reactive sulfur species: an emerging concept in oxidative stress. Biol Chem 383(3\u20134):375\u2013388","journal-title":"Biol Chem"},{"issue":"5","key":"10_CR67","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/MCG.0b013e3181c87e02","volume":"44","author":"A Khoruts","year":"2010","unstructured":"Khoruts A et al (2010) Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 44(5):354\u2013360","journal-title":"J Clin Gastroenterol"},{"issue":"Suppl 1","key":"10_CR68","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jgh.12019","volume":"28","author":"YS Roh","year":"2013","unstructured":"Roh YS, Seki E (2013) Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol 28(Suppl 1):38\u201342","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10_CR69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/PPO.0000000000000045","volume":"20","author":"CP Zambirinis","year":"2014","unstructured":"Zambirinis CP et al (2014) Pancreatic cancer, inflammation, and microbiome. Cancer J 20(3):195\u2013202","journal-title":"Cancer J"},{"issue":"4","key":"10_CR70","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrc3477","volume":"13","author":"AM Houghton","year":"2013","unstructured":"Houghton AM (2013) Mechanistic links between COPD and lung cancer. Nat Rev Cancer 13(4):233\u2013245","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098741","volume":"9","author":"BL Schmidt","year":"2014","unstructured":"Schmidt BL et al (2014) Changes in abundance of oral microbiota associated with oral cancer. PLoS One 9(6):e98741","journal-title":"PLoS One"},{"issue":"6","key":"10_CR72","doi-asserted-by":"publisher","first-page":"e00692","DOI":"10.1128\/mBio.00692-13","volume":"4","author":"JP Zackular","year":"2013","unstructured":"Zackular JP et al (2013) The gut microbiome modulates colon tumorigenesis. MBio 4(6):e00692\u2013e00613","journal-title":"MBio"},{"issue":"1","key":"10_CR73","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ibd.21354","volume":"17","author":"JC Arthur","year":"2011","unstructured":"Arthur JC, Jobin C (2011) The struggle within: microbial influences on colorectal cancer. Inflamm Bowel Dis 17(1):396\u2013409","journal-title":"Inflamm Bowel Dis"},{"key":"10_CR74","doi-asserted-by":"publisher","first-page":"15162","DOI":"10.1038\/srep15162","volume":"5","author":"S Banerjee","year":"2015","unstructured":"Banerjee S et al (2015) Distinct microbiological signatures associated with triple negative breast cancer. Sci Rep 5:15162","journal-title":"Sci Rep"},{"issue":"2","key":"10_CR75","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/01635581.2017.1263750","volume":"69","author":"TH Luu","year":"2017","unstructured":"Luu TH et al (2017) Intestinal proportion of Blautia sp. is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer. Nutr Cancer 69(2):267\u2013275","journal-title":"Nutr Cancer"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-35727-6_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T16:08:09Z","timestamp":1649952489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-35727-6_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030357269","9783030357276"],"references-count":75,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-35727-6_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"7 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}